CBIO
Crescent Biopharma, Inc.
13.90$
-2.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.02 | – | – | – | 0.00 | 0.00 | 0.00 | 1.85 | 0.54 | 0.03 | 0.00 | 1.39 | |
| 0.42 | 0.04 | 0.02 | 0.02 | 0.01 | 0.04 | – | 0.00 | 0.10 | 0.00 | – | – | – | |
| -0.42 | 0.02 | -0.02 | -0.02 | -0.01 | 0.04 | – | 0.00 | 1.75 | 0.54 | 0.03 | – | – | |
| 8.22 | 8.21 | 9.35 | 9.75 | 2.66 | 21.76 | 13.77 | 3.13 | 1.23 | 4.71 | 0.59 | 0.64 | 5.00 | |
| 7.03 | 6.70 | 7.90 | 6.31 | 6.21 | 4.90 | 4.66 | 2.32 | 0.33 | 0.36 | 0.26 | 0.29 | 0.96 | |
| 15.25 | 14.91 | 17.24 | 16.06 | 17.42 | 26.66 | 18.43 | 5.45 | 1.56 | 5.07 | 0.85 | 0.86 | 5.91 | |
| -15.25 | -14.89 | -17.24 | -16.06 | -17.42 | -26.66 | -18.43 | -5.45 | -1.56 | -4.54 | -0.81 | -0.86 | -5.52 | |
| – | – | – | – | – | 1.32 | 1.44 | 0.28 | 0.00 | 0.16 | 0.00 | 0.00 | 0.11 | |
| -14.30 | -14.10 | -16.66 | -15.66 | -15.24 | -27.71 | -19.63 | -5.65 | -1.49 | -4.48 | -0.77 | -0.81 | -5.34 | |
| – | – | – | – | – | – | – | – | – | 0.10 | – | – | – | |
| -14.30 | -14.10 | -16.66 | -15.66 | -15.24 | -27.71 | -19.63 | -5.65 | -1.49 | -4.58 | -0.77 | -0.74 | -5.34 | |
| -15.18 | -14.86 | -17.22 | -16.04 | -8.86 | 28.11 | -18.18 | -5.37 | -1.49 | -4.48 | -0.76 | -0.81 | -5.34 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.